Sensei Biotherapeutics In... (SNSE)
NASDAQ: SNSE
· Real-Time Price · USD
0.31
-0.02 (-5.52%)
At close: May 20, 2025, 3:59 PM
0.31
0.36%
After-hours: May 20, 2025, 04:16 PM EDT
-5.52% (1D)
| Bid | 0.3 |
| Market Cap | 7.74M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -29.03M |
| EPS (ttm) | -1.15 |
| PE Ratio (ttm) | -0.27 |
| Forward PE | -0.44 |
| Analyst | Buy |
| Ask | 0.34 |
| Volume | 171,345 |
| Avg. Volume (20D) | 2,791,042 |
| Open | 0.33 |
| Previous Close | 0.33 |
| Day's Range | 0.30 - 0.33 |
| 52-Week Range | 0.25 - 1.55 |
| Beta | 0.19 |
About SNSE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SNSE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SNSE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+17.99%
Sensei Biotherapeutics shares are trading higher a...
Unlock content with
Pro Subscription
1 month ago
-1.19%
Sensei Biotherapeutics shares are trading higher after the company released its preliminary dose expansion data for Solnerstotug in PD-(L)1 resistant tumors.
